AKEBIA THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2 BASKET TRIAL OF EBRIBAFUSP IN RARE COMPLEMENT-MEDIATED KIDNEY DISEASES

Reuters · 1d ago

Please log in to view news